medical cannabis
medical cannabis · page 3
- Cultivation
The Science of the Cannabis Post-Harvest Process
James Duckenfield, CEO of Glass Pharms®, explains the company’s post-harvest process, including drying and curing, and why freeze-drying is never part of it.
- Patient Access
Germany’s Medical Cannabis Insurance Reform Descends Into Chaos as Regulators Turn on Each Other
Last month, the German government passed a controversial cost-saving law that saw tens of thousands of patients denied access medical cannabis to flower reimbursed through statutory health insurance (GKV).
- Adult-Use
Thailand Presses Medical-Only Cannabis Bill Toward Cabinet as Enforcement Drive Widens
Thailand’s Ministry of Public Health is pressing ahead with a draft Cannabis and Hemp Act that would restrict its liberal cannabis market to purely medical and research use cases.
- Patient Access
‘Everything in Our Power’: German Patient Groups Fight to Overturn Cannabis Insurance Cuts
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance.
- Opinion
Opinion: New Labour Administration Can End Britain’s Failed Cannabis Experiment
Written by Omar Khan, Chief Communications and Public Affairs Officer, High Tide Inc.
- Medical Cannabis
Cannabis Use Among Teens Flat After German Partial Legalisation, But Medical Market Continues Rapid Expansion
Germany’s Cannabis Act (CanG) has not led to an increase in use among young people, according to new peer-reviewed research adding to the growing body of evidence contradicting the harms predicted by the reform’s critics.
- Opinion
Patients First: What Training the Police Taught Me About Medical Cannabis
As new national guidance instructs officers to treat medical cannabis users as patients first, James Duckenfield, CEO of Glass Pharms, reflects on what training police forces has taught him about the gap between the law and the general understanding of the legal landscape, and how the industry as a whole can help close it.
- Prescribers & Clinics
Cantourage Bets on Own Brand to Defend Flower Margins
Cantourage Group SE has announced the launch of its first proprietary medical cannabis brand for the German market, in a meaningful pivot for the distributor.
- Medical Cannabis
Curaleaf Becomes First to Register Cannabis Preparations Under Spain’s New Medical Framework
Spain’s medicines regulator has officially approved the first two oil-based preparations as part of its recently approved national medical cannabis scheme.
- Press releases
Releaf Becomes First Ever B Corp Certified Medical Cannabis Company
Releaf, the UK’s leading medical cannabis clinic, has today announced it has become the first medical cannabis clinic to achieve B Corp certification.
- Patient Access
Germany Bans Cannabis Flowers from GKV and Mandates Six-Month Trial for Extracts
Germany has today voted to ban medical cannabis flower from its statutory health insurance scheme, in a controversial move critics say will have an outsized impact on the ‘seriously ill’.
- Clinical Research
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis industry, is taking place in Arlington, Virginia.
